entertainment -WSS

entertainment

author：leisure time 2025-09-29 19:28:34 - browse：4695

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close.

What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtained by STAT. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons — a bitter legal fight in which his extramarital relationship with Langer is a contentious issue, according to the records.

Biogen spokesperson Jack Cox said the company knew about the relationship between Denner and Langer. He also said that Denner recommended Langer to Biogen’s board — he said he incorrectly stated at first that Denner nominated her — but declined to comment on the company’s vetting process and whether it planned to disclose the relationship to shareholders before they vote on Langer’s candidacy later this month. Biogen also omitted mention of the relationship from Langer’s biography in a Securities and Exchange Commission filing Tuesday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： The effects of a landmark ruling on DNA ownership are becoming clearer

focus

WSS

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Chemotherapy before breast cancer surgery might fuel metastasis

Black vets could get higher VA benefits if race not used in lung test

PBM executives asked to testify by House panel

PBM executives asked to testify by House panel

Precocious puberty in girls comes with mental health risks

knowledge

entertainment

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

As health system earnings go up, health insurance stocks go down

Hollywood unions extend contract negotiations for actors

Precocious puberty in girls comes with mental health risks

George Santos makes 1st court appearance after pleading not guilty to 13 counts

UnitedHealth quietly bought dozens of outpatient centers

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The creative science of coining drug names

Bright Health sells Medicare Advantage business to Molina

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

knowledge

Welsh Carson private equity firm escapes from FTC antitrust case

First medicine developed to treat MASH expected to be approved soon

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Primary care doctor shortage won't be solved by free med school tuition

Novo Nordisk obesity pill bests Wegovy in early trial

Amylyx ALS drug failure raises questions and concerns

leisure time

explore

focus

focus